ARKG Holdings of SLGC
SomaLogic
Solid Biosciences Inc. is a biotechnology company that focuses on developing therapies for Duchenne muscular dystrophy, a genetic disorder characterized by progressive muscle degeneration. The company generates revenue primarily through partnerships, collaborations, and milestone payments related to the development and commercialization of its drug candidates.
Trades of SLGC in ARKG
The ten most recent trades of SomaLogic in the ARKG ETF.View all trades
Date | Direction | Market Value | % of Position | % of ETF |
|---|---|---|---|---|
| Sep 21, 2023 | Buy | $217,994 | 0.76% | 0.01% |
| Sep 20, 2023 | Buy | $55,621 | 0.19% | 0.00% |
| Sep 12, 2023 | Buy | $1,899 | 0.01% | 0.00% |
| Sep 08, 2023 | Buy | $82,338 | 0.30% | 0.00% |
| Sep 06, 2023 | Buy | $280,062 | 1.04% | 0.01% |
| Apr 19, 2023 | Buy | $1,002,958 | 2.64% | 0.05% |
| Apr 18, 2023 | Buy | $1,202,522 | 3.27% | 0.06% |
| Apr 17, 2023 | Buy | $220,368 | 0.59% | 0.01% |
| Apr 10, 2023 | Buy | $52,930 | 0.16% | 0.00% |
| Apr 06, 2023 | Buy | $234,579 | 0.74% | 0.01% |